Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue

被引:3
|
作者
Tak, Eunyoung [1 ]
Hwang, Shin [2 ]
Lee, Han Chu [3 ]
Ko, Gi-Young [4 ]
Ahn, Chul-Soo [2 ]
Yoon, Young-In [2 ]
Lim, Young-Suk [3 ]
Jun, Dae-Young [1 ]
Kim, Ki-Hun [2 ]
Song, Gi-Won [2 ]
Moon, Deog-Bok [2 ]
Ryoo, Baek-Yeol [5 ]
Kim, Nayoung [1 ]
Lee, Sung-Gyu [2 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Diagnost Radiol, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Tenofovir; entecavir; covalently closed circular DNA; HBV X protein; transcatheter arterial chemoembolization; TENOFOVIR DISOPROXIL FUMARATE; CLOSED CIRCULAR DNA; HEPATOCELLULAR-CARCINOMA; IMMUNOGLOBULIN MONOTHERAPY; HBSAG SEROCLEARANCE; CLINICAL-OUTCOMES; RECURRENCE; THERAPY; RISK; TRANSPLANTATION;
D O I
10.21873/anticanres.11195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: We investigated the expression of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and HBV X protein (HBx) in human hepatocellular carcinoma (HCC) and evaluated the effect of high-concentration nucleos(t)ide analogs (NUCs) on liver tumor cell lines. Materials and Methods: This study consisted of three parts: part I used human blood and non-tumor liver tissues; part II used human HCC and adjacent liver tissues; and part III used an HBV-expressing liver tumor cell line. Results: There were close correlations among blood and liver HBV DNA and liver cccDNA. HBV cccDNA and HBx were highly up-regulated in HCC compared to adjacent liver tissues despite NUC therapy. HBV cccDNA and HBx were highly up-regulated in the cccDNA-expressing HepG2.2.15 cell line. Their expression was down-regulated and apoptosis was induced by a very high concentration of NUCs in dose-and time-dependent manner. Conclusion: Very high concentrations of NUCs may have a novel potential to kill replicating HBV-expressing liver tumor cells.
引用
收藏
页码:6059 / 6069
页数:11
相关论文
共 50 条
  • [41] Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
    Ramji, Alnoor
    Doucette, Karen
    Cooper, Curtis
    Minuk, Gerald Yosel
    Ma, Mang
    Wong, Alexander
    Wong, David
    Tam, Edward
    Conway, Brian
    Truong, David
    Wong, Philip
    Barrett, Lisa
    Ko, Hin Hin
    Haylock-Jacobs, Sarah
    Patel, Nishi
    Kaplan, Gilaad G.
    Fung, Scott
    Coffin, Carla S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (31) : 4390 - 4398
  • [42] Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection
    Ozden, Ilgin
    Kinaci, Erdem
    Ocak, Ilhan
    Colak, Mustafa
    Abdullah, Taner
    Ozcan, Funda Gumus
    Aydin, Oguzhan
    Poturoglu, Sule
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (01) : 97 - 100
  • [43] Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma
    Bulent Baran
    World Journal of Hepatology, 2015, (13) : 1742 - 1754
  • [44] Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance
    Afyon, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 654 - 655
  • [45] Hepatitis B Immunoglobulin and/or Nucleos(t)ide Analogues for Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
    Cholongitas, Evangelos
    Goulis, John
    Akriviadis, Evangelos
    Papatheodoridis, Geore V.
    LIVER TRANSPLANTATION, 2011, 17 (10) : 1176 - 1190
  • [46] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
    Lee, Teng-Yu
    Hsu, Yao-Chun
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Wu, Chun-Ying
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
  • [47] New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence
    Cholongitas, Evangelos
    Goulis, Ioannis
    Antoniadis, Nikolaos
    Fouzas, Ioannis
    Imvrios, George
    Papanikolaou, Vasilios
    Akriviadis, Evangelos
    TRANSPLANT INTERNATIONAL, 2014, 27 (10) : 1022 - 1028
  • [48] Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
    Anderson, Mark
    Gersch, Jeffery
    Luk, Ka-Cheung
    Dawson, George
    Carey, Ivana
    Agarwal, Kosh
    Shah, Pir
    Dusheiko, Geoffrey
    Lau, Daryl
    Cloherty, Gavin
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : 2029 - 2031
  • [49] NEW NUCLEOS(T)IDE ANALOGUE MONOPROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION
    Cholongitas, E.
    Goulis, J.
    Antoniadis, N.
    Fouzas, I.
    Imvrios, G.
    Vasiliadis, T.
    Papanikolaou, V.
    Akriviadis, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S370 - S371
  • [50] Eligibility for Nucleos(t)ide Analogue Treatment Disconti- nuation in Patients with Chronic Hepatitis B
    Dias, Joana Gomes
    Moradpour, Darius
    Mdawar-Bailly, Elise
    Fraga, Montserrat
    Barbosa, Joana Vieira
    SWISS MEDICAL WEEKLY, 2024, 154 : 36S - 37S